Prof. Dr. Mohammad Saleem, Head of the Pharmacology Section, completed his B. Pharm degree from Punjab University College of Pharmacy in 1992. He later earned an MS in Pharmacology and Molecular Toxicology from Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University in the USA. He obtained his Ph.D. in Pharmacology from Punjab University College of Pharmacy, specializing in Cancer & Inflammation. He also conducted post-graduate research at the University of Strasbourg in France.
He assumed the position of Professor of Pharmacology at University College of Pharmacy, University of The Punjab Lahore in 2018. Prior to that, he held academic positions including Professor of Pharmacology at Lahore College for Women University (LCWU), Associate Professor and Chairperson of the Faculty of Pharmaceutical Sciences at GC University Faisalabad, and Assistant Professor at the University of Lahore. He also gained teaching and research experience as a Graduate and Research Assistant at Arnold & Marie Schwartz College of Pharmacy, Long Island University in New York, USA.
With over 25 years of experience in teaching and research, he is an HEC approved PhD supervisor and a regular evaluator of HEC research projects. He has supervised more than 70 M.Phil. and 10 Ph.D. students and authored over 120 peer-reviewed research articles. He has been honored with the Arnold & Marie Schwartz Scholarship award for academic achievements in Pharmacology and the EGIDE French Scholarship award for PhD funding and research. He has also received the Research Productivity Awards every year from 2014 to 2021 and recently won the NRPU HEC research project worth Rs. 4.334 Million in 2022.
His research interests focus on investigating the role of natural plant extracts in cancer epigenetic modifications and inflammation. He aims to identify new molecules with anti-cancer and anti-inflammatory actions and elucidate the mechanisms by which phytochemicals modulate epigenetic modifications, apoptosis induction, and gene expression in cancer cells. His research involves various techniques such as cell culture, Elisa cell proliferation assay, DNA and RNA extraction, Real-time PCR, Western blotting, flow cytometry, and histopathological evaluations. The ultimate goal is to develop new drug targets in cancer and inflammation for clinical applications.